Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Robbins

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2009
Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugatesJohn B Robbins, Joanna Kubler-Kielb, Evguenii Vinogradov, et al.
The Journal of Infectious Diseases|December 14, 2004
The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxinsJohn B Robbins, Rachel Schneerson, Birger Trollfors, et al.
The Pediatric Infectious Disease Journal|January 24, 2009
Pertussis vaccine: a critiqueJohn B Robbins, Rachel Schneerson, Jerry M Keith, et al.
Vaccine|January 22, 2008
Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnelDarrell E Singer, Rachel Schneerson, Christian T Bautista, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2014
Toward a new vaccine for pertussisJohn B Robbins, Rachel Schneerson, Joanna Kubler-Kielb, et al.
Vaccine|August 19, 2009
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virusZuzana Biesova, Mark A Miller, Rachel Schneerson, et al.
BMC Infectious Diseases|June 21, 2013
Effects of infection and disease with Mycobacterium tuberculosis on serum antibody to glucan and arabinomannan: two surface polysaccharides of this pathogenWendy A Keitel, ZhongDong Dai, Robert W Awe, et al.
Infection and Immunity|April 16, 2002
Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivoJ Reid Schwebach, Aharona Glatman-Freedman, Leslie Gunther-Cummins, et al.
The Pediatric Infectious Disease Journal|January 24, 2009
Risk of adverse birth outcome after group B meningococcal disease: results from a Danish national cohortMichael F Howitz, Jacob Simonsen, Tyra Grove Krause, et al.
Vaccine|February 21, 2013
A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assignedShousun C Szu, Steven Hunt, Guilin Xie, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2009
Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugatesJohn B Robbins, Joanna Kubler-Kielb, Evguenii Vinogradov, et al.
The Journal of Infectious Diseases|December 14, 2004
The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxinsJohn B Robbins, Rachel Schneerson, Birger Trollfors, et al.
The Pediatric Infectious Disease Journal|January 24, 2009
Pertussis vaccine: a critiqueJohn B Robbins, Rachel Schneerson, Jerry M Keith, et al.
Vaccine|January 22, 2008
Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnelDarrell E Singer, Rachel Schneerson, Christian T Bautista, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2014
Toward a new vaccine for pertussisJohn B Robbins, Rachel Schneerson, Joanna Kubler-Kielb, et al.
Vaccine|August 19, 2009
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virusZuzana Biesova, Mark A Miller, Rachel Schneerson, et al.
BMC Infectious Diseases|June 21, 2013
Effects of infection and disease with Mycobacterium tuberculosis on serum antibody to glucan and arabinomannan: two surface polysaccharides of this pathogenWendy A Keitel, ZhongDong Dai, Robert W Awe, et al.
Infection and Immunity|April 16, 2002
Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivoJ Reid Schwebach, Aharona Glatman-Freedman, Leslie Gunther-Cummins, et al.
The Pediatric Infectious Disease Journal|January 24, 2009
Risk of adverse birth outcome after group B meningococcal disease: results from a Danish national cohortMichael F Howitz, Jacob Simonsen, Tyra Grove Krause, et al.
Vaccine|February 21, 2013
A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assignedShousun C Szu, Steven Hunt, Guilin Xie, et al.
Pageof 6